Infectious Disease & Vaccines
Part of Biotech - Drug Development
 MRK | Merck & Co., Inc. | $315.6b | $128.25 | +0.0% | 5.0M |
 GILD | Gilead Sciences Inc | $161.7b | $130.09 | -0.7% | 6.6M |
 PFE | Pfizer Inc. | $142.7b | $26.13 | +1.1% | 44.2M |
 MRNA | Moderna, Inc. Common Stock | $22.0b | $54.58 | -4.2% | 4.9M |
 SMMT | Summit Therapeutics Inc. Common Stock | $10.4b | $13.63 | +0.1% | 1.9M |
 PCVX | Vaxcyte, Inc. Common Stock | $7.7b | $58.64 | +5.4% | 1.1M |
 BCRX | BioCryst Pharmaceuticals Inc | $2.3b | $9.32 | +2.6% | 3.4M |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.5b | $8.81 | -3.7% | 2.3M |
 NVAX | Novavax Inc | $1.2b | $7.74 | +0.6% | 4.5M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.9b | $4.61 | -1.7% | 983.8K |
 CRMD | CorMedix Inc. | $0.6b | $7.45 | +1.1% | 523.5K |
 ASMB | Assembly Biosciences, Inc | $497.6m | $26.50 | -0.0% | 81.9K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $376.1m | $4.88 | +5.3% | 212.0K |
 EBS | Emergent Biosolutions, Inc. | $372.5m | $5.34 | -29.7% | 3.9M |
 ENTA | Enanta Pharmaceuticals, Inc | $366.4m | $13.32 | +0.8% | 142.5K |
 SIGA | SIGA Technologies Inc. | $230.2m | $3.14 | -0.8% | 418.3K |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $192.7m | $5.97 | +4.4% | 191.6K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $170.0m | $11.70 | +3.5% | 201.1K |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $166.7m | $4.69 | 0.0% | 100.4K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $163.7m | $6.24 | -3.0% | 301.4K |
 IVVD | Invivyd, Inc. Common Stock | $157.6m | $0.67 | +8.3% | 3.0M |
 ZTEK | Zentek Ltd. Common Stock | $85.3m | $0.65 | +1.8% | 89.7K |
 XBIT | XBiotech Inc | $68.1m | $2.29 | +0.4% | 9.0K |
 SPRO | Spero Therapeutics, Inc. Common Stock | $66.6m | $1.26 | +0.8% | 732.2K |
 INO | Inovio Pharmaceuticals, Inc. | $55.7m | $0.67 | -1.6% | 1.7M |
 SCYX | SCYNEXIS, Inc. | $50.3m | $5.32 | +1.4% | 65.9K |
 MCRB | Seres Therapeutics, Inc. | $48.7m | $4.79 | -3.8% | 79.0K |
 IBO | Impact BioMedical, Inc. | $46.4m | $0.44 | +4.8% | 29.1K |
 NNVC | NanoViricides Inc. | $39.5m | $1.36 | -4.2% | 229.2K |
 TVGN | Tevogen Inc. Common Stock | $29.6m | $6.71 | -6.1% | 10.1K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $26.2m | $5.27 | +17.3% | 262.0K |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $22.1m | $11.55 | +2.8% | 12.4K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $20.6m | $2.42 | 0.0% | 30.2K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $11.3m | $1.02 | 0.0% | 26.8K |
 TRAW | Traws Pharma, Inc. Common Stock | $7.2m | $0.52 | 0.0% | 51.3K |
 AIM | AIM ImmunoTech Inc. | $7.0m | $0.27 | -5.1% | 3.2M |
 IMNN | Imunon, Inc. Common Stock | $6.7m | $1.65 | -2.5% | 36.4K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $6.4m | $0.80 | 0.0% | N/A |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $6.2m | $1.46 | -0.7% | 61.4K |
 XBIO | Xenetic Biosciences, Inc. | $6.1m | $2.89 | 0.0% | 11.2K |
 SNGX | Soligenix, Inc. Common Stock | $5.6m | $0.39 | -0.8% | 127.6K |
 CODX | Co-Diagnostics, Inc. Common Stock | $5.3m | $1.40 | -6.0% | 729.8K |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 GOVX | GeoVax Labs, Inc. New | $3.5m | $0.76 | +1.8% | 125.3K |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $3.1m | $1.18 | -4.5% | 47.3K |
 MBRX | Moleculin Biotech, Inc. | $3.0m | $0.39 | -1.1% | 2.1M |
 SBFM | Sunshine Biopharma Inc. | $2.8m | $1.40 | +5.3% | 250.6K |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $2.3m | $2.75 | -0.3% | 75.5K |
 PHGE | BiomX Inc. | $2.0m | $0.16 | -8.7% | 3.2M |
 AEMD | AETHLON MEDICAL INC | $1.7m | $3.03 | -5.5% | 69.6K |